Monday, June 30, 2025 6/30/2025

The role of ferroptosis in red cell aging in vivo and in vitro

Award Number: R01HL146442
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2019
PERIOD OF PERFORMANCE END DATE: 04/30/2028

Group Awards By:

View Award Description

The role of ferroptosis in red cell aging in vivo and in vitro - PROJECT SUMMARY Red blood cells (RBCs) are a perfect model to study oxidant stress. RBCs are the most abundant cell in the body (84% of total human cells) and play an essential role in oxygen transport and thus in the regulation of all oxygen-dependent metabolic processes. To facilitate this task, RBCs are loaded with hemoglobin (Hb) and iron. Indeed, 66% of total bodily iron is in RBCs. As a result, the mature RBC faces significant oxidant stress deriving from iron-dependent Fenton and Haber-Weiss redox chemistry. The lack of nuclei and organelles prevents RBCs from synthesizing new proteins to replace oxidatively damaged components during the average lifespan of 120 days in circulation. Every day over 200 billion RBCs are removed from the bloodstream and de novo generated via erythropoiesis, a process that relies on the uptake of circulating iron in the ferric (oxidized) state, and its reduction to the ferrous state. This process is catalyzed by the ferrireductase STEAP3 – a transcriptionally-regulated target of tumor protein p53. Both p53 and STEAP3 are critical to erythropoiesis and polymorphic in humans, whereby mutations in p53 - occurring in >50% of all cancers, 0.2% of all healthy humans - are not just inherited, but commonly accumulate during organismal aging or exposure to carcinogens. In genetic studies on murine models of in vitro aging of RBCs (i.e., under conditions that mimic blood storage in the blood bank) we have documented that hypermorphic STEAP3 is associated with poor blood storage quality, owing to increased oxidant stress and elevated lipid peroxidation. Iron-mediated non-apoptotic cell death via lipid peroxidation is a hallmark of ferroptosis, a novel process of cell death investigated extensively in nucleated cells, but hitherto ignored in iron-loaded RBCs. More than other cells, RBCs rely on antioxidant systems to keep oxidant stress in check. A key antioxidant system is represented by the soluble tripeptide glutathione, glutathione-dependent detoxification systems (e.g., glutathione-peroxidase 4 - GPX4 to counteract lipid peroxidation) and oxidized glutathione recycling via NADPH-dependent enzymes. The main pathway that sustains NADPH synthesis in RBCs is the pentose phosphate pathway. Glucose 6-phoshate dehydrogenase (G6PD) is the rate-limiting enzyme of this pathway, an X-linked gene that is mutated in ~500 million people. Oxidant damage to protein triggers formation of isoaspartyl damage, a process counteracted by the enzyme PIMT. Relevant to this proposal, in other cell types p53 promotes ferroptosis by up-regulation of STEAP3 and down-regulation of G6PD, while being itself negatively regulated by PIMT. Even though genetic and pharmacological tools are available to regulate ferroptosis, these approaches are untested in mature RBCs, which is the focus of this project. Relevance to public health: RBC responses to hypoxia and oxidant stress regulate hemolysis, an etiological contributor to physio/pathological adaptations to pro-oxidant challenges in vivo (e.g., high altitude, exercise) or ex vivo, such as blood bank storage of RBCs for transfusion purposes, ranked 1st in the list of breakthroughs in the history of mankind that are credited with saving the most lives.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $710,391 )
2025	2025	THE REGENTS OF THE UNIV. OF COLORADO	13001 E 17TH PL STE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	002	7	4/28/2025	NON-COMPETING CONTINUATION	$710,391
2025	2024	THE REGENTS OF THE UNIV. OF COLORADO	13001 E 17TH PL STE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	001	6	3/28/2025	COMPETING CONTINUATION	$9,834
2025	2023	THE REGENTS OF THE UNIV. OF COLORADO	13001 E 17TH PL STE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	000	5	3/28/2025	NON-COMPETING CONTINUATION	-$9,834
														Subtotal = $710,391

Issue Date FY: 2024 ( Subtotal = $724,266 )
2024	2024	THE REGENTS OF THE UNIVERSITY OF COLORADO	13001 E 17TH PL STE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	000	6	2/15/2024	COMPETING CONTINUATION	$724,266
														Subtotal = $724,266

Issue Date FY: 2023 ( Subtotal = $605,807 )
2023	2023	REGENTS OF THE UNIVERSITY OF COLORADO, THE	13001 E 17TH PLACE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	001	5	8/30/2023	NON-COMPETING CONTINUATION	$0
2023	2023	REGENTS OF THE UNIVERSITY OF COLORADO, THE	13001 E 17TH PLACE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	000	5	4/18/2023	NON-COMPETING CONTINUATION	$605,807
														Subtotal = $605,807

Issue Date FY: 2022 ( Subtotal = $605,807 )
2022	2022	REGENTS OF THE UNIVERSITY OF COLORADO, THE	13001 E 17TH PLACE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	000	4	4/7/2022	NON-COMPETING CONTINUATION	$545,224
2022	2022	REGENTS OF THE UNIVERSITY OF COLORADO, THE	13001 E 17TH PLACE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	001	4	6/8/2022	NON-COMPETING CONTINUATION	$60,583
														Subtotal = $605,807

Issue Date FY: 2021 ( Subtotal = $605,807 )
2021	2021	REGENTS OF THE UNIVERSITY OF COLORADO, THE	13001 E 17TH PLACE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	000	3	5/14/2021	NON-COMPETING CONTINUATION	$605,807
														Subtotal = $605,807

Issue Date FY: 2020 ( Subtotal = $605,807 )
2020	2020	REGENTS OF THE UNIVERSITY OF COLORADO, THE	13001 E 17TH PLACE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	000	2	4/23/2020	NON-COMPETING CONTINUATION	$605,807
														Subtotal = $605,807

Issue Date FY: 2019 ( Subtotal = $699,682 )
2019	2019	REGENTS OF THE UNIVERSITY OF COLORADO, THE	13001 E 17TH PLACE F428	AURORA	CO	80045	ADAMS	USA	Blood Diseases and Resources Research	000	1	7/24/2019	NEW	$699,682
														Subtotal = $699,682

Grand Total All Awards = $4,557,567

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The role of ferroptosis in red cell aging in vivo and in vitro

Award Number: R01HL146442

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2019

PERIOD OF PERFORMANCE END DATE: 04/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer